Systemic chemotherapy is the standard treatment for stage IV gastric cancer (GC) [1].
Considering gc,1˅2, the proportion of duplicate pairs with non-missing genotypes that shared 1 or 2 alleles IBS when using translation constant c, all 662 loci had gc*,1˅2 > 0.954, and 655 had gc*,1˅2 = 1.
Helicobacter pylori (H. pylori) has been etiologically linked with primary gastric lymphoma (PGL) and gastric carcinoma (GC) [ 1, 2].
Synthesis of the TRβ-selective thyromimetic GC-1 has been improved using methoxymethyl (MOM) and triisopropylsilyl (TiPS) substituents as phenolic protecting groups.
We synthesized an analogue of the thyromimetic GC-1 bearing the same hydrophobic appendage as the estrogen receptor antagonist ICI-164,384.
This sensor can be combined with our previously published TRβ-1 biosensor to detect potentially therapeutic subtype-selective compounds such as GC-1 and KB-141.
The effect of several TRβ ligands, including the TRβ selective agonist GC-1 and the TRβ selective antagonist NH-3, were investigated.
While having reduced affinity for the thyroid hormone receptors compared to GC-1, it behaves in a manner consistent with a competitive antagonist in a transactivation assay.
In all experiments performed in this study no differences were observed between GC-1 cells grown in culture medium and GC-1 cells exposed to DMSO.
GC-1 cells grown in culture medium supplemented with DMSO were used as the control.
The GC-1 cell line was obtained from ATCC CRL-20533; Manassas, VA, USA).
